Unlocking the next generation of
Our goal is to create a Bio-Sustainable Future.
BSF Enterprise, the owner of pioneering UK-based clinical and cellular agriculture company 3D Bio-Tissues, is unlocking the next generation of biotech solutions. It is achieving this through an acquisition-led growth strategy to drive the development of lab-grown tissues. Cell-based tissue engineering can generate cultured meat, lab-grown leather, human corneas, collagen growth and skin substitutes. This technology will contribute to a radical transformation of the delivery of sustainable solutions across a variety of sectors.
Investing in the rapidly growing tissue engineering market.
BSF owns 100% of 3D Bio Tissues (3DBT), a tissue engineering company with patent-protected IP that is already producing human corneas that could help restore vision to millions of people. 3DBT has three strands of IP, each with a different sector focus, development and revenue timeline:
Serum-free media: 3DBT’s City-mix™ is an animal-free cell growth agent for culturing skin, muscle & fat cells which will be used for lab-grown meat and leather production.
Skin Care Products: Lipopeptide Etsyl™ actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.
Tissue Templating Application: using a platform to grow tissues with natural structure & function such as corneas, lab-grown meat and leather & human skin substitutes.
Why BSF Enterprise.
Patented technology produces the highest quality animal tissue.
Proprietary ‘Tissue Templating’ technology produces tissue with natural structure and function.
Diverse products with near-term revenue opportunities.
Animal-free cell growth agent, cultured meat and leather, skin, skincare, and substitute corneas.
Operating in rapidly growing markets.
410% CAGR (2021 to 2030) for lab-grown meat; 12.7m people awaiting cornea transplant.
History of translating innovations from lab bench to commercial success.
3D Bio-Tissues’ team is comprised of globally recognised experts in cell biology and tissue engineering.
Pioneered the UK’s first fillet of cultured meat.
A transformational and high-profile development that demonstrates BSF’s cutting-edge technology.